Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

XTL-2125 studied for chronic hepatitis C in new phase I trial

May 5, 2006

GLOBE study reveals resistance and efficacy with telbivudine in hepatitis B

May 4, 2006

Seroconversion seen with hepatitis B vaccine in phase IIa trial

May 4, 2006

Pharmacokinetics, safety and activity of pradefovir reported

May 3, 2006

Studies in vivo reveal anti-hepatitis C virus effects of DEBIO-025

May 3, 2006

Satavaptan improves hyponatremia in cirrhosis patients

May 3, 2006

E1 vaccination evaluated in patients with hepatitis C genotype 1 infection

May 3, 2006

Study reveals activity of CPG-10101 alone and with peginterferon in hepatitis C

May 2, 2006

HCV-796 well tolerated in healthy subjects

May 2, 2006

R-1626 safe and active in chronic hepatitis C

May 2, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 7, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.